Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 133 articles:
HTML format
Text format



Single Articles


    May 2017
  1. RADES D, Maderer A, Panzner A, Hunold P, et al
    Phase I Study of Definitive Radio-chemotherapy with Cisplatin, 5-Fluorouracil and Cetuximab for Unresectable Locally Advanced Esophageal Cancer.
    Anticancer Res. 2017;37:2703-2708.
    PubMed     Text format     Abstract available


  2. ZIVICOVA V, Broz P, Fik Z, Mifkova A, et al
    Genome-wide Expression Profiling (with Focus on the Galectin Network) in Tumor, Transition Zone and Normal Tissue of Head and Neck Cancer: Marked Differences Between Individual Patients and the Site of Specimen Origin.
    Anticancer Res. 2017;37:2275-2288.
    PubMed     Text format     Abstract available


  3. HAGEMANN J, Jacobi C, Hahn M, Schmid V, et al
    Spheroid-based 3D Cell Cultures Enable Personalized Therapy Testing and Drug Discovery in Head and Neck Cancer.
    Anticancer Res. 2017;37:2201-2210.
    PubMed     Text format     Abstract available


    April 2017
  4. VEGH D, Banyai D, Hermann P, Nemeth Z, et al
    Type-2 Diabetes Mellitus and Oral Tumors in Hungary: A Long-term Comparative Epidemiological Study.
    Anticancer Res. 2017;37:1853-1857.
    PubMed     Text format     Abstract available


  5. DAVE E, Su W, Gupta V, Miles B, et al
    Human Papilloma Virus-positive Oropharyngeal Squamous Cell Carcinoma in the Elderly.
    Anticancer Res. 2017;37:1847-1851.
    PubMed     Text format     Abstract available


  6. JO S, Ha TK, Han SH, Kim ME, et al
    Myricetin Induces Apoptosis of Human Anaplastic Thyroid Cancer Cells via Mitochondria Dysfunction.
    Anticancer Res. 2017;37:1705-1710.
    PubMed     Text format     Abstract available


  7. P NS, Kang DY, Kim BJ, Joung YH, et al
    Methylsulfonylmethane Induces G1 Arrest and Mitochondrial Apoptosis in YD-38 Gingival Cancer Cells.
    Anticancer Res. 2017;37:1637-1646.
    PubMed     Text format     Abstract available


  8. SHIMIZU H, Shiozaki A, Fujiwara H, Konishi H, et al
    Short- and Long-term Progress of Recurrent Laryngeal Nerve Paralysis After Subtotal Esophagectomy.
    Anticancer Res. 2017;37:2019-2023.
    PubMed     Text format     Abstract available


  9. YUNOKI T, Tabuchi Y, Hayashi A
    Expression of Anti-apoptotic Protein BAG3 in Human Sebaceous Gland Carcinoma of the Eyelid.
    Anticancer Res. 2017;37:1931-1934.
    PubMed     Text format     Abstract available


  10. FANG CY, Liew PL, Chen CL, Lin YH, et al
    High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1891-1899.
    PubMed     Text format     Abstract available


  11. FUJIMURA T, Takahashi K, Kambayashi Y, Furudate S, et al
    Retrospective Investigation of Cutaneous Squamous Cell Carcinoma on the Lip Treated with Peplomycin Administered Through a Superficial Temporal Artery.
    Anticancer Res. 2017;37:1885-1889.
    PubMed     Text format     Abstract available


    March 2017
  12. WAKITA A, Motoyama S, Nanjo H, Sato Y, et al
    PD-L1 Expression Is a Prognostic Factor in Patients with Thoracic Esophageal Cancer Treated Without Adjuvant Chemotherapy.
    Anticancer Res. 2017;37:1433-1441.
    PubMed     Text format     Abstract available


  13. TORII C, Hida Y, Shindoh M, Akiyama K, et al
    Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1219-1225.
    PubMed     Text format     Abstract available


  14. NAKASHIMA S, Shiozaki A, Ichikawa D, Hikami S, et al
    Transient Receptor Potential Melastatin 7 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1161-1167.
    PubMed     Text format     Abstract available


  15. TSENG HH, Tseng YK, You JJ, Kang BH, et al
    Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
    Anticancer Res. 2017;37:1059-1066.
    PubMed     Text format     Abstract available


  16. RUSSO M, Malandrino P, Moleti M, D'Angelo A, et al
    Thyroid Cancer in the Pediatric Age in Sicily: Influence of the Volcanic Environment.
    Anticancer Res. 2017;37:1515-1522.
    PubMed     Text format     Abstract available


  17. KOGASHIWA Y, Yasuda M, Sakurai H, Nakahira M, et al
    PD-L1 Expression Confers Better Prognosis in Locally Advanced Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1417-1424.
    PubMed     Text format     Abstract available


  18. THEOCHARIS S, Kotta-Loizou I, Giaginis C, Alexandrou P, et al
    Expression and Clinical Significance of Concomitant FAK/SRC and p-Paxillin in Mobile Tongue Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1313-1319.
    PubMed     Text format     Abstract available


  19. SAKAGAMI H, Masuda Y, Tomomura M, Yokose S, et al
    Quantitative Structure-Cytotoxicity Relationship of Chalcones.
    Anticancer Res. 2017;37:1091-1098.
    PubMed     Text format     Abstract available


  20. TAKEDA D, Hasegawa T, Ueha T, Iwata E, et al
    Induced Pluripotent-stem-cell Related Genes Contribute to De-differentiation in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1075-1082.
    PubMed     Text format     Abstract available


  21. HARA K, Miyazaki T, Yokobori T, Yoshida T, et al
    Significance and Function of MicroRNA-7 in Oesophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1043-1048.
    PubMed     Text format     Abstract available


  22. SAKAGAMI H, Okudaira N, Masuda Y, Amano O, et al
    Induction of Apoptosis in Human Oral Keratinocyte by Doxorubicin.
    Anticancer Res. 2017;37:1023-1029.
    PubMed     Text format     Abstract available


    February 2017
  23. SAKAGUCHI M, Maebayashi T, Aizawa T, Ishibashi N, et al
    Clinical Outcomes of Hypopharyngeal Cancer Receiving Definitive Radiotherapy with Concurrent Chemotherapy.
    Anticancer Res. 2017;37:941-947.
    PubMed     Text format     Abstract available


  24. SASAKI K, Uchikado Y, Okumura H, Omoto I, et al
    Role of 18F-FDG-PET/CT in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy.
    Anticancer Res. 2017;37:859-864.
    PubMed     Text format     Abstract available


  25. GAMEZ ME, Agarwal M, Hu KS, Lukens JN, et al
    Hypofractionated Palliative Radiotherapy with Concurrent Radiosensitizing Chemotherapy for Advanced Head and Neck Cancer Using the "QUAD-SHOT Regimen".
    Anticancer Res. 2017;37:685-691.
    PubMed     Text format     Abstract available


  26. WICHMANN G, Cedra S, Schlegel D, Kolb M, et al
    Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells Ex Vivo.
    Anticancer Res. 2017;37:521-527.
    PubMed     Text format     Abstract available


  27. VRANA D, Matzenauer M, Aujesky R, Vrba R, et al
    Potential Predictive Role of MicroRNAs in the Neoadjuvant Treatment of Esophageal Cancer.
    Anticancer Res. 2017;37:403-412.
    PubMed     Text format     Abstract available


  28. BOPPANA NB, Kraveka JM, Rahmaniyan M, Li LI, et al
    Fumonisin B1 Inhibits Endoplasmic Reticulum Stress Associated-apoptosis After FoscanPDT Combined with C6-Pyridinium Ceramide or Fenretinide.
    Anticancer Res. 2017;37:455-463.
    PubMed     Text format     Abstract available


  29. SIVARS L, Landin D, Grun N, Vlastos A, et al
    Validation of Human Papillomavirus as a Favourable Prognostic Marker and Analysis of CD8+ Tumour-infiltrating Lymphocytes and Other Biomarkers in Cancer of Unknown Primary in the Head and Neck Region.
    Anticancer Res. 2017;37:665-673.
    PubMed     Text format     Abstract available


  30. MEGWALU UC, Ma Y
    Racial Disparities in Oropharyngeal Cancer Stage at Diagnosis.
    Anticancer Res. 2017;37:835-839.
    PubMed     Text format     Abstract available


  31. HOCH S, Thelen K, Vorwerk H, Netzer C, et al
    Impact of Different Treatment Concepts on Regional Failure in Advanced Oropharyngeal Cancer.
    Anticancer Res. 2017;37:727-734.
    PubMed     Text format     Abstract available


    January 2017
  32. BAKST RL, Su W
    Identification and Management of Head and Neck Cancer Recurrences Detected on Adjuvant Radiation Oncology Simulation Scans.
    Anticancer Res. 2017;37:229-232.
    PubMed     Text format     Abstract available


  33. IMAI T, Oue N, Sentani K, Sakamoto N, et al
    KIF11 Is Required for Spheroid Formation by Oesophageal and Colorectal Cancer Cells.
    Anticancer Res. 2017;37:47-55.
    PubMed     Text format     Abstract available


    December 2016
  34. LIU J, Motoyama S, Sato Y, Wakita A, et al
    Decreased Skeletal Muscle Mass After Neoadjuvant Therapy Correlates with Poor Prognosis in Patients with Esophageal Cancer.
    Anticancer Res. 2016;36:6677-6685.
    PubMed     Text format     Abstract available


  35. SHIRAI K, Saitoh JI, Musha A, Abe T, et al
    Clinical Outcomes of Definitive and Postoperative Radiotherapy for Stage I-IVB Hypopharyngeal Cancer.
    Anticancer Res. 2016;36:6571-6578.
    PubMed     Text format     Abstract available


  36. MIYAZAKI T, Sakai M, Sohda M, Tanaka N, et al
    Prognostic Significance of Inflammatory and Nutritional Parameters in Patients with Esophageal Cancer.
    Anticancer Res. 2016;36:6557-6562.
    PubMed     Text format     Abstract available


  37. SEIDL D, Schild SE, Wollenberg B, Hakim SG, et al
    Prognostic Factors in Patients Irradiated for Recurrent Head-and-Neck Cancer.
    Anticancer Res. 2016;36:6547-6550.
    PubMed     Text format     Abstract available


  38. OHASHI T, Komatsu S, Ichikawa D, Miyamae M, et al
    Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2016;36:6457-6466.
    PubMed     Text format     Abstract available


  39. MELLER S, VAN Ellen A, Gevensleben H, Bicker A, et al
    Ectopic Myoglobin Expression Is Associated with a Favourable Outcome in Head and Neck Squamous Cell Carcinoma Patients.
    Anticancer Res. 2016;36:6235-6241.
    PubMed     Text format     Abstract available


  40. DE FELICE F, Abate G, Galdieri A, Bulzonetti N, et al
    Impact of Induction Chemotherapy in Locally Advanced HPV-negative Oropharyngeal Cancer. A Propensity Score-matched analysis.
    Anticancer Res. 2016;36:6667-6672.
    PubMed     Text format     Abstract available


  41. GORPHE P, Matias M, Even C, Ferte C, et al
    Laryngo-esophageal Dysfunction-free Survival in a Preservation Protocol for T3 Laryngeal Squamous-cell Carcinoma.
    Anticancer Res. 2016;36:6625-6630.
    PubMed     Text format     Abstract available


  42. HAN MW, Lee JC, Park SY, Kim YM, et al
    Homotypic Interaction of Stabilin-2 Plays a Critical Role in Lymph Node Metastasis of Tongue Cancer.
    Anticancer Res. 2016;36:6611-6618.
    PubMed     Text format     Abstract available


  43. OBATA K, Shimo T, Okui T, Matsumoto K, et al
    Tachykinin Receptor 3 Distribution in Human Oral Squamous Cell Carcinoma.
    Anticancer Res. 2016;36:6335-6341.
    PubMed     Text format     Abstract available


  44. LEE C, Siu A, Ramos DM
    Multicellular Spheroids as a Model for Hypoxia-induced EMT.
    Anticancer Res. 2016;36:6259-6263.
    PubMed     Text format     Abstract available


    November 2016
  45. VASSILIOU S, Nkenke E, Lefantzis N, Ioannidis A, et al
    Effect of Olmesartan on the Level of Oral Cancer Risk Factor PAI1.
    Anticancer Res. 2016;36:6093-6096.
    PubMed     Text format     Abstract available


  46. TAKANO K, Kakuki T, Obata K, Nomura K, et al
    The Behavior and Role of Lipolysis-stimulated Lipoprotein Receptor, a Component of Tricellular Tight Junctions, in Head and Neck Squamous Cell Carcinomas.
    Anticancer Res. 2016;36:5895-5904.
    PubMed     Text format     Abstract available


  47. ASAKA S, Shimakawa T, Yamaguchi K, Murayama M, et al
    The Influence of Neoadjuvant Chemotherapy with Docetaxel, Nedaplatin and 5-Fluorouracil After Esophagectomy.
    Anticancer Res. 2016;36:6165-6171.
    PubMed     Text format     Abstract available


  48. KAMATA YU, Sumida T, Murase R, Nakano H, et al
    Blockade of Androgen-induced Malignant Phenotypes by Flutamide Administration in Human Salivary Duct Carcinoma Cells.
    Anticancer Res. 2016;36:6071-6075.
    PubMed     Text format     Abstract available


  49. SUZUKI R, Matsushima Y, Okudaira N, Sakagami H, et al
    Cytotoxic Components Against Human Oral Squamous Cell Carcinoma Isolated from Andrographis paniculata.
    Anticancer Res. 2016;36:5931-5935.
    PubMed     Text format     Abstract available


  50. HARADA K, Ferdous T, Ueyama Y
    Gimeracil Exerts Radiosensitizing Effects on Oral Squamous Cell Carcinoma Cells In Vitro and In Vivo.
    Anticancer Res. 2016;36:5923-5930.
    PubMed     Text format     Abstract available


    October 2016
  51. YAMAZAKI H, Demizu Y, Okimoto T, Ogita M, et al
    Comparison of Re-irradiation Outcomes for Charged Particle Radiotherapy and Robotic Stereotactic Radiotherapy Using CyberKnife for Recurrent Head and Neck Cancers: A Multi-institutional Matched-cohort Analysis.
    Anticancer Res. 2016;36:5507-5514.
    PubMed     Text format     Abstract available


  52. ATTRAMADAL CG, Kumar S, Gao J, Boysen ME, et al
    Low Mast Cell Density Predicts Poor Prognosis in Oral Squamous Cell Carcinoma and Reduces Survival in Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2016;36:5499-5506.
    PubMed     Text format     Abstract available


  53. KUDOU M, Shiozaki A, Fujiwara H, Konishi H, et al
    Efficacy of PET-CT in the Diagnosis and Treatment of Recurrence After Esophageal Cancer Surgery.
    Anticancer Res. 2016;36:5473-5480.
    PubMed     Text format     Abstract available


  54. RADES D, Seidl D, Wollenberg B, Schild SE, et al
    Radiochemotherapy with Paclitaxel for Recurrent Previously Irradiated Squamous Cell Carcinoma of the Head and Neck.
    Anticancer Res. 2016;36:5463-5468.
    PubMed     Text format     Abstract available


  55. KITAGAWA H, Namikawa T, Munekage M, Fujisawa K, et al
    Analysis of Factors Associated with Weight Loss After Esophagectomy for Esophageal Cancer.
    Anticancer Res. 2016;36:5409-5412.
    PubMed     Text format     Abstract available


  56. MORIKAWA T, Koto M, Hasegawa A, Takagi R, et al
    Radiation-induced Parotid Gland Atrophy in Patients with Head and Neck Cancer After Carbon-ion Radiotherapy.
    Anticancer Res. 2016;36:5403-5407.
    PubMed     Text format     Abstract available


  57. LEE M, Ryu CH, Chang HW, Kim GC, et al
    Radiotherapy-associated Furin Expression and Tumor Invasiveness in Recurrent Laryngeal Cancer.
    Anticancer Res. 2016;36:5117-5125.
    PubMed     Text format     Abstract available


  58. DAMASKOS C, Valsami S, Spartalis E, Antoniou EA, et al
    Histone Deacetylase Inhibitors: A Novel Therapeutic Weapon Against Medullary Thyroid Cancer?
    Anticancer Res. 2016;36:5019-5024.
    PubMed     Text format     Abstract available


  59. MEGWALU UC
    Exploring the Use of Oropharyngeal Cancer Histology to Account for HPV Status in Population-based Studies.
    Anticancer Res. 2016;36:5515-5518.
    PubMed     Text format     Abstract available


  60. KNIEF J, Reddemann K, Petrova E, Herhahn T, et al
    High Density of Tumor-infiltrating B-Lymphocytes and Plasma Cells Signifies Prolonged Overall Survival in Adenocarcinoma of the Esophagogastric Junction.
    Anticancer Res. 2016;36:5339-5345.
    PubMed     Text format     Abstract available


    September 2016
  61. KIKUCHI M, Nakajima M, Muroi H, Takahashi M, et al
    Significance of Expression of Complement C4d in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2016;36:4553-7.
    PubMed     Text format     Abstract available


  62. MATSUMURA Y, Hiraoka K, Ishikawa K, Shoji Y, et al
    CD40 Expression in Human Esophageal Squamous Cell Carcinoma Is Associated with Tumor Progression and Lymph Node Metastasis.
    Anticancer Res. 2016;36:4467-75.
    PubMed     Text format     Abstract available


    August 2016
  63. GROSS M, Meirovich A, Rachmut J, Kalichman I, et al
    The Diagnostic and Prognostic Value of sIL-2R as an Immune Biomarker in Head and Neck Cancers.
    Anticancer Res. 2016;36:4347-52.
    PubMed     Text format     Abstract available


  64. DE FELICE F, Musio D, Bulzonetti N, Maghella F, et al
    Target Volume Delineation Based on Diffusion-weighted magnetic Resonance Imaging for Locally Advanced Head and Neck Cancer.
    Anticancer Res. 2016;36:4181-5.
    PubMed     Text format     Abstract available


  65. THEODORAKI MN, Lorenz KJ, Schneider J, Thierauf JC, et al
    Influence of Photodynamic Therapy on the Expression of Cancer/Testis Antigens in Squamous Cell Carcinoma of the Head and Neck.
    Anticancer Res. 2016;36:3973-82.
    PubMed     Text format     Abstract available


  66. SAYAN M, Vempati P, Miles B, Teng M, et al
    Adjuvant Therapy for Salivary Gland Carcinomas.
    Anticancer Res. 2016;36:4165-70.
    PubMed     Text format     Abstract available


  67. ISRAEL Y, Rachmiel A, Ziv G, Nagler R, et al
    Benign and Malignant Salivary Gland Tumors - Clinical and Demographic Characteristics.
    Anticancer Res. 2016;36:4151-4.
    PubMed     Text format     Abstract available


  68. SUMIDA T, Kobayashi Y, Ishikawa A, Shinohara K, et al
    Bite Force and Masticatory Performance Using Implant-supported Overdentures After Treatment of Mandibular Cancer.
    Anticancer Res. 2016;36:4077-80.
    PubMed     Text format     Abstract available


  69. KITAGAWA H, Yatabe T, Namikawa T, Munekage M, et al
    Postoperative Closed-loop Glycemic Control Using an Artificial Pancreas in Patients After Esophagectomy.
    Anticancer Res. 2016;36:4063-7.
    PubMed     Text format     Abstract available


  70. MORITA M, Saeki H, Nakaji YU, Zaitsu Y, et al
    Conversion to Neuroendocrine Carcinoma from Squamous Cell Carcinoma of the Esophagus After Definitive Chemoradiotherapy.
    Anticancer Res. 2016;36:4045-9.
    PubMed     Text format     Abstract available


  71. MAYS AC, Feng X, Browne JD, Sullivan CA, et al
    Chemokine and Chemokine Receptor Profiles in Metastatic Salivary Adenoid Cystic Carcinoma.
    Anticancer Res. 2016;36:4013-8.
    PubMed     Text format     Abstract available


  72. ZATONSKI T, Ciesielska U, Nowinska K, Ratajczak-Wielgomas K, et al
    Expression of Cell Cycle-Related Proteins p16, p27, p53 and Ki-67 in HPV-positive and -negative Samples of Papillomas of the Upper Respiratory Tract.
    Anticancer Res. 2016;36:3917-24.
    PubMed     Text format     Abstract available


  73. SUMIDA T, Kamata YU, Kobayashi Y, Ishikawa A, et al
    ID1 Controls Aggressiveness of Salivary Gland Cancer Cells via Crosstalk of IGF and AKT Pathways.
    Anticancer Res. 2016;36:3865-70.
    PubMed     Text format     Abstract available


  74. LEE C, Ramos DM
    Regulation of Multicellular Spheroids by MAPK and FYN Kinase.
    Anticancer Res. 2016;36:3833-8.
    PubMed     Text format     Abstract available


  75. KARAGIANNIS AK, Girio-Fragkoulakis C, Nakouti T
    Procalcitonin: A New Biomarker for Medullary Thyroid Cancer? A Systematic Review.
    Anticancer Res. 2016;36:3803-10.
    PubMed     Text format     Abstract available



  76. Salivary Gland Neoplasms.
    Anticancer Res. 2016;36:4372.
    PubMed     Text format    


    July 2016
  77. TSAI CW, Chang WS, Gong CL, Shih LC, et al
    Contribution of Matrix Metallopeptidase-1 Genotypes, Smoking, Alcohol Drinking and Areca Chewing to Nasopharyngeal Carcinoma Susceptibility.
    Anticancer Res. 2016;36:3335-3340.
    PubMed     Text format     Abstract available


  78. JOHNSON SD, Levingston C, Young MR
    Premalignant Oral Lesion Cells Elicit Increased Cytokine Production and Activation of T-cells.
    Anticancer Res. 2016;36:3261-70.
    PubMed     Text format     Abstract available


  79. FRANZESE C, Fogliata A, Franceschini D, Clerici E, et al
    Treatment: Outcome and Toxicity of Volumetric Modulated Arc Therapy in Oropharyngeal Carcinoma.
    Anticancer Res. 2016;36:3451-7.
    PubMed     Text format     Abstract available


    June 2016

  80. Targeting Oral Cancer.
    Anticancer Res. 2016;36:3224.
    PubMed     Text format    


  81. KOBAYASHI Y, Sumida T, Ishikawa A, Mori Y, et al
    The Contribution of Dental Implants to Functional Artificial Restoration After Treatment of Oral Cancer.
    Anticancer Res. 2016;36:3053-6.
    PubMed     Text format     Abstract available


  82. AMPIL F, Caldito G, Vora M, Richards T, et al
    Ten-year Survivors After Contemporary Management of Advanced 'Horseshoe' Anterior Commissure Laryngeal Cancer.
    Anticancer Res. 2016;36:3049-52.
    PubMed     Text format     Abstract available


  83. RADES D, Janssen S, Bajrovic A, Strojan P, et al
    A Total Radiation Dose of 70 Gy Is Required After Macroscopically Incomplete Resection of Squamous Cell Carcinoma of the Head and Neck.
    Anticancer Res. 2016;36:2989-92.
    PubMed     Text format     Abstract available


  84. MEGWALU UC, Panossian H
    Survival Outcomes in Early Stage Laryngeal Cancer.
    Anticancer Res. 2016;36:2903-7.
    PubMed     Text format     Abstract available


  85. BOYSEN ME, Zatterstrom UK, Evensen JF
    Self-reported Symptoms to Monitor Recurrent Head and Neck Cancer-Analysis of 1,678 Cases.
    Anticancer Res. 2016;36:2849-54.
    PubMed     Text format     Abstract available


  86. WIEST I, Alexiou C, Friese K, Betz P, et al
    Expression of the Tumor-associated Mucin 1 Epitope Analyzed with the Humanized PankoMab-GEX Antibody in Malignant and Normal Tissues of the Head and Neck.
    Anticancer Res. 2016;36:3179-84.
    PubMed     Text format     Abstract available


  87. FRIEDRICH RE, Wunder T, Schumacher U, Bartel-Friedrich S, et al
    Expression of DOG1 (Using SP31) in Poorly Differentiated Carcinoma of the Head and Neck.
    Anticancer Res. 2016;36:3117-22.
    PubMed     Text format     Abstract available


  88. GORKA E, Fabo D, Gezsi A, Czirbesz K, et al
    Distance from Primary Tumor Is the Strongest Predictor for Early Onset of Brain Metastases in Melanoma.
    Anticancer Res. 2016;36:3065-9.
    PubMed     Text format     Abstract available


  89. MEGWALU UC, Green RW
    Total Thyroidectomy Versus Lobectomy for the Treatment of Follicular Thyroid Microcarcinoma.
    Anticancer Res. 2016;36:2899-902.
    PubMed     Text format     Abstract available


  90. KRAMER B, Hock C, Birk R, Sauter A, et al
    Targeted Therapies in HPV-positive and -negative HNSCC - Alteration of EGFR and VEGFR-2 Expression In Vitro.
    Anticancer Res. 2016;36:2799-807.
    PubMed     Text format     Abstract available


  91. SUMIDA T, Ishikawa A, Kamata YU, Nakano H, et al
    Estrogen Enhances Malignant Phenotypes in Human Salivary Adenoid Cystic Carcinoma Cells.
    Anticancer Res. 2016;36:2793-8.
    PubMed     Text format     Abstract available


  92. MASUI M, Okui T, Shimo T, Takabatake K, et al
    Novel Midkine Inhibitor iMDK Inhibits Tumor Growth and Angiogenesis in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2016;36:2775-81.
    PubMed     Text format     Abstract available


    May 2016
  93. SEIDL D, Janssen S, Strojan P, Bajrovic A, et al
    Prognostic Factors After Definitive Radio(Chemo)Therapy of Locally Advanced Head and Neck Cancer.
    Anticancer Res. 2016;36:2523-6.
    PubMed     Text format     Abstract available


  94. SEIDL D, Janssen S, Strojan P, Hakim SG, et al
    Importance of Chemotherapy and Radiation Dose After Microscopically Incomplete Resection of Stage III/IV Head and Neck Cancer.
    Anticancer Res. 2016;36:2487-91.
    PubMed     Text format     Abstract available


  95. HSU CM, Lin PM, Lin HC, Lai CC, et al
    Altered Expression of Imprinted Genes in Squamous Cell Carcinoma of the Head and Neck.
    Anticancer Res. 2016;36:2251-8.
    PubMed     Text format     Abstract available


  96. TONISSI F, Lattanzio L, Astesana V, Cavicchioli F, et al
    Reoxygenation Reverses Hypoxia-related Radioresistance in Head and Neck Cancer Cell Lines.
    Anticancer Res. 2016;36:2211-5.
    PubMed     Text format     Abstract available


  97. SHIBATA A, Ibaragi S, Mandai H, Tsumura T, et al
    Synthetic Terrein Inhibits Progression of Head and Neck Cancer by Suppressing Angiogenin Production.
    Anticancer Res. 2016;36:2161-8.
    PubMed     Text format     Abstract available


  98. RANTANEN T, Oksala N, Sand J
    Adenocarcinoma of the Oesophagus and Oesophagogastric Junction: Analysis of Incidence and Risk Factors.
    Anticancer Res. 2016;36:2323-9.
    PubMed     Text format     Abstract available


  99. HAKELIUS M, Reyhani V, Rubin K, Gerdin B, et al
    Normal Oral Keratinocytes and Head and Neck Squamous Carcinoma Cells Induce an Innate Response of Fibroblasts.
    Anticancer Res. 2016;36:2131-7.
    PubMed     Text format     Abstract available


    April 2016
  100. MATSUMOTO A, Nishikawa K, Yuda M, Tanaka Y, et al
    Early Response of Esophageal Cancer to Neoadjuvant Chemotherapy with Docetaxel-Cisplatin-5-Fluorouracil Represents Sensitivity: A Phase II Study.
    Anticancer Res. 2016;36:1937-42.
    PubMed     Text format     Abstract available


  101. KANEKIYO S, Takeda S, Nakajima M, Nishiyama M, et al
    Efficacy and Safety of Biweekly Docetaxel in Combination with Nedaplatin as Second-line Chemotherapy for Unresectable or Recurrent Esophageal Cancer.
    Anticancer Res. 2016;36:1923-7.
    PubMed     Text format     Abstract available


  102. DANG RP, LE VH, Miles BA, Teng MS, et al
    Clinical Outcomes in Patients with Recurrent or Metastatic Human Papilloma Virus-positive Head and Neck Cancer.
    Anticancer Res. 2016;36:1703-9.
    PubMed     Text format     Abstract available


  103. MOLES MA, Montoya JA, Salvago MD, Avila IR, et al
    Implications of Differential Expression of beta-Catenin in Oral Carcinoma.
    Anticancer Res. 2016;36:1599-604.
    PubMed     Text format     Abstract available


  104. RADES D, Janssen S, Kasmann L, Bolm L, et al
    Outcomes After Irradiation of Epidural Spinal Cord Compression Due to Metastatic Thyroid Cancer.
    Anticancer Res. 2016;36:2035-9.
    PubMed     Text format     Abstract available


    March 2016
  105. IWASAKI K, Osaka Y, Tachibana S, Suda T, et al
    Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Local or Metastatic Esophageal Cancer.
    Anticancer Res. 2016;36:987-94.
    PubMed     Text format     Abstract available


  106. HOCH S, Bohne F, Franke N, Wilhelm T, et al
    Extent of Salvage Neck Dissection in Advanced Oro- and Hypopharyngeal Cancer.
    Anticancer Res. 2016;36:981-6.
    PubMed     Text format     Abstract available


  107. BLEDSOE TJ, Noble AR, Reddy CA, Burkey BB, et al
    Split-Course Accelerated Hypofractionated Radiotherapy (SCAHRT): A Safe and Effective Option for Head and Neck Cancer in the Elderly or Infirm.
    Anticancer Res. 2016;36:933-9.
    PubMed     Text format     Abstract available


    February 2016
  108. LONDERO SC, Jespersen ML, Krogdahl A, Bastholt L, et al
    Gene-expression Classifier in Papillary Thyroid Carcinoma: Validation and Application of a Classifier for Prognostication.
    Anticancer Res. 2016;36:749-56.
    PubMed     Text format     Abstract available


  109. LU YC, Lin ML, Su HL, Chen SS, et al
    ER-Dependent Ca++-mediated Cytosolic ROS as an Effector for Induction of Mitochondrial Apoptotic and ATM-JNK Signal Pathways in Gallic Acid-treated Human Oral Cancer Cells.
    Anticancer Res. 2016;36:697-705.
    PubMed     Text format     Abstract available


  110. TURUNEN A, Hukkanen V, Kulmala J, Syrjanen S, et al
    HSV-1 Infection Modulates the Radioresponse of a HPV16-positive Head and Neck Cancer Cell Line.
    Anticancer Res. 2016;36:565-74.
    PubMed     Text format     Abstract available


  111. SIVARS L, Tani E, Nasman A, Ramqvist T, et al
    Human Papillomavirus as a Diagnostic and Prognostic Tool in Cancer of Unknown Primary in the Head and Neck Region.
    Anticancer Res. 2016;36:487-93.
    PubMed     Text format     Abstract available


  112. OJIMA T, Nakamori M, Nakamura M, Katsuda M, et al
    Neoadjuvant Chemotherapy with Divided-dose Docetaxel, Cisplatin and Fluorouracil for Patients with Squamous Cell Carcinoma of the Esophagus.
    Anticancer Res. 2016;36:829-34.
    PubMed     Text format     Abstract available


  113. NOBLE AR, Greskovich JF, Han J, Reddy CA, et al
    Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
    Anticancer Res. 2016;36:785-92.
    PubMed     Text format     Abstract available


  114. WINTHER M, Alsner J, Sorensen BS, Wittrup CF, et al
    Hypoxia-regulated MicroRNAs in Gastroesophageal Cancer.
    Anticancer Res. 2016;36:721-30.
    PubMed     Text format     Abstract available


    January 2016

  115. Esophageal Cancer. Prevention, Diagnosis and Therapy.
    Anticancer Res. 2016;36:481.
    PubMed     Text format    


  116. TANI Y, Nakajima M, Kikuchi M, Ihara K, et al
    18F-Fluorodeoxyglucose Positron Emission Tomography for Evaluating the Response to Neoadjuvant Chemotherapy in Advanced Esophageal Cancer.
    Anticancer Res. 2016;36:367-73.
    PubMed     Text format     Abstract available


  117. JI Y, Li X, Li Y, Zhong Y, et al
    Aldehyde Dehydrogenase-1 Expression Predicts Unfavorable Outcomes in Patients with Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2016;36:343-9.
    PubMed     Text format     Abstract available


  118. MEHTA V, Shi Z, Mills GM, Nathan CA, et al
    Effect of Payer Status on Relative Survival of Patients with Laryngeal Cancer.
    Anticancer Res. 2016;36:327-33.
    PubMed     Text format     Abstract available


  119. ALHAZZAZI TY, Kamarajan P, Xu Y, Ai T, et al
    A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells.
    Anticancer Res. 2016;36:49-60.
    PubMed     Text format     Abstract available


  120. KANTHAMNENI N, Yung B, Lee RJ
    Effect of Eudragit on In Vitro Transfection Efficiency of PEI-DNA Complexes.
    Anticancer Res. 2016;36:81-5.
    PubMed     Text format     Abstract available


  121. ADAMS S, Lin J, Brown D, Shriver CD, et al
    Ultraviolet Radiation Exposure and the Incidence of Oral, Pharyngeal and Cervical Cancer and Melanoma: An Analysis of the SEER Data.
    Anticancer Res. 2016;36:233-7.
    PubMed     Text format     Abstract available


    December 2015
  122. KOMATSU M, Arai Y, Yabuki K, Sano D, et al
    Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Nasopharyngeal Carcinoma.
    Anticancer Res. 2015;35:6861-7.
    PubMed     Text format     Abstract available


  123. SONG JH, Jeong BK, Choi HS, Jeong H, et al
    Comparison of Failure Patterns Between Conventional and Intensity-modulated Radiotherapy for Stage III and IV Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2015;35:6833-40.
    PubMed     Text format     Abstract available


  124. KIM SH, Kang JG, Kim CS, Ihm SH, et al
    Suppression of AKT Potentiates Synergistic Cytotoxicity of Apigenin with TRAIL in Anaplastic Thyroid Carcinoma Cells.
    Anticancer Res. 2015;35:6529-37.
    PubMed     Text format     Abstract available


  125. OKUMURA H, Uchikado Y, Omoto I, Motomura M, et al
    Ferredoxin Reductase Is Useful for Predicting the Effect of Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2015;35:6471-4.
    PubMed     Text format     Abstract available


  126. PAPADAKIS G, Kalaitzidou S, Triantafillou E, Drosou A, et al
    Biochemical Effects of Levothyroxine Withdrawal in Patients with Differentiated Thyroid Cancer.
    Anticancer Res. 2015;35:6933-40.
    PubMed     Text format     Abstract available


    November 2015
  127. DOLL C, Arsenic R, Lage H, Johrens K, et al
    Expression of Estrogen Receptors in OSCC in Relation to Histopathological Grade.
    Anticancer Res. 2015;35:5867-72.
    PubMed     Text format     Abstract available


  128. GALLO K, Brickman A, Warren WH, Gattuso P, et al
    Unresectable Middle Mediastinal Biphasic Pulmonary Blastoma.
    Anticancer Res. 2015;35:6325-7.
    PubMed     Text format     Abstract available


  129. KITAGAWA H, Namikawa T, Munekage M, Akimori T, et al
    Visualization of the Stomach's Arterial Networks During Esophageal Surgery Using the HyperEye Medical System.
    Anticancer Res. 2015;35:6201-5.
    PubMed     Text format     Abstract available


  130. KLAIRMONT M, Kopkash K, Favuzza J, Hill M, et al
    Four Synchronous Primary Malignancies of the Breast, Lung, Colon and Esophagus.
    Anticancer Res. 2015;35:6159-62.
    PubMed     Text format     Abstract available


  131. ATTRAMADAL CG, Kumar S, Boysen ME, Dhakal HP, et al
    Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas.
    Anticancer Res. 2015;35:6111-20.
    PubMed     Text format     Abstract available


    October 2015
  132. MANYAM BV, Nwizu TI, Rahe ML, Harr BA, et al
    Early and Severe Radiation Toxicity Associated with Concurrent Sirolimus in an Organ Transplant Recipient with Head and Neck Cutaneous Squamous Cell Carcinoma: A Case Report.
    Anticancer Res. 2015;35:5511-4.
    PubMed     Text format     Abstract available


  133. SUROV A, Gottschling S, Wienke A, Meyer HJ, et al
    Primary Thyroid Sarcoma: A Systematic Review.
    Anticancer Res. 2015;35:5185-91.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: